(Q28202824)
Statements
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study (English)
0 references
15 January 2003
0 references
21
0 references
2
0 references
211-22
0 references